Cancer Research Meeting Calendar  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 3226-3230, August 1, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sulman, E. P.
Right arrow Articles by Brodeur, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sulman, E. P.
Right arrow Articles by Brodeur, G. M.

Identification of a Consistent Region of Allelic Loss on 1p32 in Meningiomas: Correlation with Increased Morbidity1

Erik P. Sulman, Jan P. Dumanski, Peter S. White, Huaqing Zhao, John M. Maris, Tiit Mathiesen, Carl Bruder, Avital Cnaan and Garrett M. Brodeur2

Divisions of Oncology [E. P. S., P. S. W., J. M. M., G. M. B.] and Biostatistics and Epidemiology [H. Z., A. C.], Children's Hospital of Philadelphia, and Department of Pediatrics [J. M. M., A. C., G. M. B.], University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; and Departments of Neurosurgery [T. M.] and Clinical Genetics [J. P. D., C. B.], Karolinska Hospital, S-104 01 Stockholm, Sweden

Meningioma is a common tumor of the central nervous system. Deletions of the short arm of chromsome 1 (1p) are the second most commonly observed chromosomal abnormality in these tumors. Here, we analyzed tumor and normal DNAs from 157 meningioma patients using PCR-based polymorphic loci. Loss of heterozygosity (LOH) for at least one informative marker on 1p was observed in 54 cases (34%), whereas LOH on 1q occurred in only 9 cases (8%). High-resolution deletion mapping defined a consensus region of deletion flanked distally by D1S2713 and proximally by D1S2134, which spans 1.5 cM within 1p32. LOH in this region has also been observed in several other malignancies, suggesting the presence of a tumor suppressor gene or genes that are important for several types of cancer. Statistical analysis revealed that 1p LOH was associated with chromosome 22 deletions and with abnormalities of the NF2 gene in meningioma. In addition, unlike other clinical and molecular characteristics, only 1p LOH was shown to be significantly associated with recurrence-free survival.

1 This work was supported by NIH Grants CA-39771 and 5U10-CA15488-23, the Audrey E. Evans Endowed Chair, the Swedish Cancer Society, and the Swedish Medical Research Council.

2 To whom requests for reprints should be addressed, at Division of Oncology, Children's Hospital of Philadelphia, Room 902D, Abramson Research Center, 324 South 34th Street, Philadelphia, PA 19104-4318. Phone: (215) 590-2817; Fax: (215) 590-3770; E-mail: brodeur@email.chop.edu.

Received 3/ 2/98. Accepted 6/16/98.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Lee, H. L. Miller, H. R. Russell, K. Boyd, T. Curran, and P. J. McKinnon
Patched2 modulates tumorigenesis in patched1 heterozygous mice.
Cancer Res., July 15, 2006; 66(14): 6964 - 6971.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. G. Buckley, C. Jarbo, U. Menzel, T. Mathiesen, C. Scott, S. G. Gregory, C. F. Langford, and J. P. Dumanski
Comprehensive DNA Copy Number Profiling of Meningioma Using a Chromosome 1 Tiling Path Microarray Identifies Novel Candidate Tumor Suppressor Loci
Cancer Res., April 1, 2005; 65(7): 2653 - 2661.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
D G R Evans, C Watson, A King, A J Wallace, and M E Baser
Multiple meningiomas: differential involvement of the NF2 gene in children and adults
J. Med. Genet., January 1, 2005; 42(1): 45 - 48.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Asgharian, Y.-J. Chen, N. J. Patronas, P. L. Peghini, J. C. Reynolds, A. Vortmeyer, Z. Zhuang, D. J. Venzon, F. Gibril, and R. T. Jensen
Meningiomas May Be a Component Tumor of Multiple Endocrine Neoplasia Type 1
Clin. Cancer Res., February 1, 2004; 10(3): 869 - 880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Bostrom, B. Meyer-Puttlitz, M. Wolter, B. Blaschke, R. G. Weber, P. Lichter, K. Ichimura, V. P. Collins, and G. Reifenberger
Alterations of the Tumor Suppressor Genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in Atypical and Anaplastic Meningiomas
Am. J. Pathol., August 1, 2001; 159(2): 661 - 669.
[Abstract] [Full Text]


Home page
J. Mol. Diagn.Home page
J. Mora, N.-K. V. Cheung, B. H. Kushner, M. P. LaQuaglia, K. Kramer, M. Fazzari, G. Heller, L. Chen, and W. L. Gerald
Clinical Categories of Neuroblastoma Are Associated with Different Patterns of Loss of Heterozygosity on Chromosome Arm 1p
J. Mol. Diagn., February 1, 2000; 2(1): 37 - 46.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Z.-G. Wang, P. S. White, and S. H. Ackerman
Atp11p and Atp12p Are Assembly Factors for the F1-ATPase in Human Mitochondria
J. Biol. Chem., August 10, 2001; 276(33): 30773 - 30778.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.